Published in J Chromatogr on January 21, 1976
Determination of nomifensine by a sensitive radioimmunoassay. Br J Clin Pharmacol (1977) 0.88
A simple gas chromatographic method for the determination of nomifensine in plasma and a comparison of the method with other available techniques. Br J Clin Pharmacol (1977) 0.84
Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation (1975) 1.92
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent. J Chromatogr (1979) 1.30
[Comparative study of gastro-intestinal blood loss after antrafenine, aspirin and placebo in healthy volunteers (author's transl)]. Therapie (1981) 1.28
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Pharmacokinetics of nomifensine in man. Psychopharmacologia (1975) 1.12
Inter-observer and intra-observer variability of mammogram interpretation: a field study. Eur J Cancer (1992) 1.09
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer (2005) 1.07
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
The requirements of a specialist Breast Centre. Eur J Cancer (2013) 1.04
Incorporating activity of ribosomes and integrity of ribosomal RNA. Biochem Biophys Res Commun (1970) 1.04
[Acute diltiazem poisoning: kinetic and hemodynamics study]. J Toxicol Clin Exp (1991) 1.03
A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol (2001) 1.00
Basic metabolites of trazodone in humans. Arzneimittelforschung (1974) 1.00
Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr (1978) 0.99
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography. Cancer Treat Rep (1976) 0.98
EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl) (1994) 0.95
Inter-observer variability in the interpretation of mammograms. Tumori (1988) 0.95
Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. Br J Clin Pharmacol (1980) 0.94
Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem. Drug Metab Rev (1992) 0.91
A gas chromatographic method for the determination of amantadine in human plasma. J Chromatogr (1972) 0.91
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol (2002) 0.90
Application of gas chromatography-chemical ionization mass fragmentography in the evaluation of bases and nucleoside analogues used in cancer chemotherapy. J Chromatogr (1974) 0.89
Non-extraction HPLC method for simultaneous measurement of dyphylline and doxofylline in serum. Clin Chem (1990) 0.89
[Neurolytic block of the celiac plexus and splanchnic nerves with computed tomography. The experience in 150 cases and an optimization of the technic]. Radiol Med (1999) 0.89
Determination of progabide and its main acid metabolite in biological fluids using high-performance liquid chromatography and electrochemical detection. Application to the measurement of blood/plasma partition ratio. J Chromatogr (1984) 0.89
Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine. Ann Allergy (1992) 0.89
Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch (2000) 0.88
Mass fragmentography as an application of gas-liquid chromatography-mass spectrometry in biological research. J Chromatogr (1972) 0.88
Infants born to hypertensive mothers treated by acebutolol. Pharmacological studies in the perinatal period. Dev Pharmacol Ther (1982) 0.88
Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.87
Long-term monitoring of tricyclic antidepressant plasma concentrations. Br J Psychiatry (1980) 0.87
Plasma protein binding of zolpidem in liver and renal insufficiency. Int J Clin Pharmacol Ther Toxicol (1988) 0.86
Analysis of tricyclic antidepressant drugs by gas chromatography using nitrogen-selective detection with packed and capillary columns. J Chromatogr (1980) 0.86
Beta-blockade and blood-levels after low-dose oral propranolol: The hepatic "first-pass" threshold revisited. Lancet (1978) 0.86
Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci (2006) 0.86
Gas chromatographic degradation of several drugs and their metabolites. Anal Chem (1973) 0.85
Pharmacokinetics of propranolol in normal healthy volunteers. J Pharmacokinet Biopharm (1977) 0.85
Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. Br J Clin Pharmacol (1980) 0.84
High-performance liquid and gas chromatographic methods for the determination of cicloprolol. J Chromatogr (1990) 0.84
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile. J Pharmacol Exp Ther (1996) 0.84
Carbamazepine: biotransformation. Adv Neurol (1975) 0.84
Analytical profile of trazodone. Arzneimittelforschung (1973) 0.84
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. Br J Clin Pharmacol (1980) 0.83
Pharmacokinetics of theophylline: a dose-range study. Br J Clin Pharmacol (1982) 0.83
Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion. J Pharm Biomed Anal (1985) 0.82
Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. Clin Pharmacol Ther (1992) 0.82
Some aspects of interindividual variations in the metabolism of xenobiotics. Inflamm Res (2003) 0.82
Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients. Fundam Clin Pharmacol (1993) 0.82
EEG profile of litoxetine after single and repeated administration in healthy volunteers. Br J Clin Pharmacol (1994) 0.82
Zolpidem excretion in breast milk. Eur J Clin Pharmacol (1989) 0.82
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings]. Br J Clin Pharmacol (1979) 0.82
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly. Psychopharmacology (Berl) (1980) 0.81
High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study. Arch Gen Psychiatry (1982) 0.81
Determination of mephenesin in plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr (1990) 0.81
Gas chromatographic-mass spectrometric studies on carbamazepine. Adv Biochem Psychopharmacol (1973) 0.80
Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bioavailability studies. J Pharm Biomed Anal (1987) 0.80
Brain distribution of propranolol in the rat. Eur J Pharmacol (1979) 0.80
In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. Pol J Pharmacol (2002) 0.80
Metabolism of vincamine in the rat in vivo and in vitro. Arzneimittelforschung (1980) 0.80
Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol (1977) 0.80
Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn. Eur J Clin Pharmacol (1980) 0.80
Pharmacokinetics of indomethacin in the premature infant. Dev Pharmacol Ther (1980) 0.80
Simple and specific high performance liquid chromatographic method for the routine monitoring of clonazepam in plasma. Ther Drug Monit (1980) 0.80
Pharmacokinetics and metabolism of diltiazem in man. Acta Cardiol (1980) 0.80
Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry (1999) 0.80
A method for the determination of imipramine in human plasma by gas-liquid chromatography-mass fragmentography. J Chromatogr (1972) 0.79
Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings]. Br J Clin Pharmacol (1979) 0.79
Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures. Eur J Clin Pharmacol (1986) 0.79
Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicity. Int J Cancer (1975) 0.79
Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination. Drug Metab Dispos (2000) 0.79
Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine. Eur J Clin Pharmacol (1996) 0.79
Cimetropium bromide as a relaxant for the radiological examination of the stomach and duodenum. Curr Med Res Opin (1986) 0.79
Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function. Eur J Drug Metab Pharmacokinet (1984) 0.79
Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows. Reproduction (2001) 0.79
Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat. J Pharmacol Exp Ther (1980) 0.79
Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration. Arzneimittelforschung (1980) 0.79
Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine. J Pharm Sci (1972) 0.79
Formation of stable epoxides in the metabolism of tricyclic drugs. Drug Metab Rev (1976) 0.78
Quantitative determination of naproxen in plasma by a simple high-performance liquid chromatographic method. J Chromatogr (1981) 0.78
Positive chronotropic effect of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations. Eur J Pharmacol (1976) 0.78
Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings]. Br J Clin Pharmacol (1979) 0.78
Iminostilbene--a metabolite of carbamazepine isolated from rat urine. J Pharm Pharmacol (1973) 0.78
Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings]. Br J Clin Pharmacol (1979) 0.78
Xenobiotic metabolizing enzymes in fish: diversity, regulation and biomarkers for pollutant exposure. Acta Physiol Hung (1996) 0.78
Effect of degradation of rat-liver ribosomal RNA on the structure of the ribosomal subunits. Eur J Biochem (1972) 0.78
Mass spectrometric characterization of some human metabolites of flumecinol. Biomed Environ Mass Spectrom (1988) 0.78
Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid. Eur J Clin Pharmacol (1987) 0.77
Hypothalamic Motivational Processes as Reflected by their Hippocampal Electrical Correlates. Science (1965) 0.77
Proportional incidence and radiological review of large (T2+) breast cancers as surrogate indicators of screening programme performance. Eur Radiol (2011) 0.77
Analysis of proportional incidence and review of interval cancer cases observed within the mammography screening programme in Trento province, Italy. Radiol Med (2011) 0.77
[A rationale basis for airways conditioning: too wet or not too wet? ]. Minerva Anestesiol (2003) 0.77
10,11-Dihydro-10,11-dihydroxy-5H-dibenz(b,f)azepine-5-carboxamide, a metabolite of carbamazepine isolated from human and rat urine. J Med Chem (1973) 0.77
Enhanced effect of haloperidol and apomorphine after hypophysectomy: pharmacokinetic considerations. J Pharm Pharmacol (1983) 0.76
Pharmacokinetics of antihypertensive drugs in the neonatal period. Dev Pharmacol Ther (1989) 0.76
[In vivo bioequivalence study of Sulpirid (GYKI-Alkaloida) and Dogmatil fort (Delagrange) 200 mg sulpiride tablets in healthy volunteers]. Acta Pharm Hung (1992) 0.76